Triple

T22404506
Position Surface form Disambiguated ID Type / Status
Subject Directive 2001/83/EC E553846 entity
Predicate fullName P16 FINISHED
Object Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use E553846 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use | Statement: [Directive 2001/83/EC, fullName, Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use
Context triple: [Directive 2001/83/EC, fullName, Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use]
  • A. Regulation (EC) No 141/2000 on orphan medicinal products
    Regulation (EC) No 141/2000 on orphan medicinal products is a key European Union law that establishes incentives and a special approval framework to encourage the development and marketing of medicines for rare diseases.
  • B. Council Directive 93/42/EEC on medical devices
    Council Directive 93/42/EEC on medical devices was a key European Union legislative framework that set essential safety and performance requirements for medical devices marketed within the EU.
  • C. Directive 98/79/EC on in vitro diagnostic medical devices
    Directive 98/79/EC on in vitro diagnostic medical devices was an EU legal framework that set safety, performance, and conformity requirements for in vitro diagnostic medical devices placed on the European market.
  • D. Directive 2001/83/EC chosen
    Directive 2001/83/EC is a key European Union law that sets the framework for the authorization, manufacture, distribution, and pharmacovigilance of medicinal products for human use across EU member states.
  • E. European Union pharmaceutical legislation
    European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e4da7048190b4387d422a9a0de5 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f158b6762c8190991fc14c5ca8e609 completed April 29, 2026, 1:02 a.m.
NED1 Entity disambiguation (via context triple) batch_6a0ae9cfabe081908d6a001bcfe5372c completed May 18, 2026, 10:28 a.m.
Created at: April 16, 2026, 8:46 p.m.